Company / Total Assets
Vir Biotechnology, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.0B
FY2025
5-year range
$1.0B / $2.8B
FY2021-FY2025
Trend
-28.3%
vs FY2024
Sector context
#81 of 214
Health Care
What the data says
At $1.0B, Vir Biotechnology, Inc.'s total assets ranks #81 of 214 in the Health Care sector. Total Assets has declined for 3 consecutive years, from $2.8B in FY2022 to $1.0B in FY2025.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +1.8%.
Declined from $1.9B to $1.0B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -29.0%
- 5-Year CAGR
- +1.8%
- 10-Year CAGR
- -
Sector benchmark
#81 of 214 in Health CareTop 38% of 214This company $1.0B Sector average $7.5B
▼
-86.6% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of +1.8%, indicating consistent growth.
- In FY2025, total assets decreased 28.3% year-over-year.
- Ranks #81 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | -28.3% |
| FY2024 | $1.4B | -27.1% |
| FY2023 | $1.9B | -31.5% |
| FY2022 | $2.8B | +43.4% |
| FY2021 | $2.0B | +112.7% |
| FY2020 | $918.8M | +79.4% |
| FY2019 | $512.1M | +167.3% |
| FY2018 | $191.6M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026